Detalhe da pesquisa
1.
Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea.
Am J Cardiovasc Drugs;
24(2): 313-324, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38413500
2.
Systematic Review of the Economic Evaluation of Sodium-Glucose Cotransporter-2 Inhibitors Used as Treatment in Patients with Heart Failure.
Clin Drug Investig;
43(7): 463-474, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365452